23 May 2013
Keywords: Kamada, Cheisi, Alpha-1 antitrypsin, Distribution
Article | 08 August 2012
Israeli biopharma company Kamada (KMDA: TA) has entered into an exclusive agreement with privately-owned Italian drugmaker Chiesi Farmaceutici for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 August 2012
22 May 2013
© 2013 thepharmaletter.com